Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis

CB Castro, CB Dias, H Hillebrandt, HR Sohrabi… - Nutrition …, 2023 - academic.oup.com
Abstract Context In preclinical Alzheimer's disease (AD), the brain gradually becomes
insulin resistant. As a result, brain glucose utilization is compromised, causing a cellular …
被引用次数：10 相关文章

Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: A systematic review and meta-analysis

CB Castro, CB Dias, H Hillebrandt, HR Sohrabi… - 2023 - ro.ecu.edu.au
Abstract Context: In preclinical Alzheimer's disease (AD), the brain gradually becomes
insulin resistant. As a result, brain glucose utilization is compromised, causing a cellular …

Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis

CB Castro, CB Dias, H Hillebrandt… - Nutrition …, 2023 - researchers.mq.edu.au
Abstract Context: In preclinical Alzheimer's disease (AD), the brain gradually becomes
insulin resistant. As a result, brain glucose utilization is compromised, causing a cellular …

Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis.

CB Castro, CB Dias, H Hillebrandt, HR Sohrabi… - Nutrition …, 2023 - europepmc.org
Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic
review and meta-analysis. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis

CB Castro, CB Dias, H Hillebrandt, HR Sohrabi… - Nutrition …, 2023 - academic.oup.com
Abstract Context In preclinical Alzheimer's disease (AD), the brain gradually becomes
insulin resistant. As a result, brain glucose utilization is compromised, causing a cellular …

Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis.

CB Castro, CB Dias, H Hillebrandt, HR Sohrabi… - 2023 - cabidigitallibrary.org
Abstract Context: In preclinical Alzheimer's disease (AD), the brain gradually becomes
insulin resistant. As a result, brain glucose utilization is compromised, causing a cellular …
[PDF] researchgate.net

[PDF][PDF] Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis

CB Castro, CB Dias, H Hillebrandt, HR Sohrabi… - researchgate.net
The rise in the number of older adults has been associated with increased rates of cognitive
decline and dementia, with a profound impact on morbidity and mortality and considerable …

Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis

CB Castro, CB Dias, H Hillebrandt… - Nutrition …, 2023 - pubmed.ncbi.nlm.nih.gov
Context In preclinical Alzheimer's disease (AD), the brain gradually becomes insulin
resistant. As a result, brain glucose utilization is compromised, causing a cellular energy …

Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis

C Castro, CB Dias, H Hillebrandt… - Nutrition …, 2023 - researchportal.murdoch.edu.au
In preclinical Alzheimer's disease (AD), the brain gradually becomes insulin resistant. As a
result, brain glucose utilization is compromised, causing a cellular energy deficit that leads …